The efficacy of prostaglandin F2-alpha in second-trimester abortion. Coagulation and hormonal aspects.
D000028:Abortion, Induced; D000653:Amniotic Fluid / Q000032:analysis; D001777:Blood Coagulation / Q000187:drug effects*; D001779:Blood Coagulation Factors / Q000032:analysis; D001792:Blood Platelets / Q000187:drug effects; D002404:Catheterization; D055598:Chemical Phenomena; D002621:Chemistry; D003475:Curettage; D004106:Dilatation; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D006801:Humans; D006854:Hydrocortisone / Q000032:analysis; D007047:Hysterosalpingography; D007267:Injections; D010063:Ovum; D010920:Placenta / Q000601:surgery; D011247:Pregnancy; D011374:Progesterone / Q000032:analysis; D011453:Prostaglandins / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D012965:Sodium Chloride / Q000627:therapeutic use; D013997:Time Factors; D014599:Uterus / Q000503:physiopathology
D001779:Blood Coagulation Factors; D011453:Prostaglandins; D012965:Sodium Chloride; D011374:Progesterone; D005340:Fibrinogen; D006854:Hydrocortisone